Prevention and treatment of respiratory tract disease
AssigneeThe UAB Research Foundation
InventorsGail W. Wertz, Qingzhong Yu
Life of this patent
Estimating the term…
Abstract
Recombinant methods for recovering wildtype or engineered negative stranded, non-segmented RNA virus genomes containing non-coding 3' and 5' regions (e.g. leader or trailer regions) surrounding one, several or all of the genes of the virus or one or more heterologous gene(s) in the form of ribonucleocapsids containing N, P and L proteins, which are capable of replicating and assembling with the remaining structural proteins to bud and form virions, or which are only capable of infecting one cell, or are defective interfering particles, are disclosed. Novel vaccines, gene therapy vectors and antiviral compounds are also disclosed.
Claims12
A pure, recombinant, virus particle, which, upon entering a host cell, replicates and buds progeny virions, comprising:
- 1) a functional non-segmented respiratory syncytial virus RNA dependent RNA polymerase (L);
- 2) a non-segmented respiratory syncytial virus phosphoprotein (P);
- 3) a non-segmented respiratory syncytial virus nucleocapsid (N);
- 4) necessary non-segmented respiratory syncytial virus structural proteins;
- 5) a 3' non-coding RNA sequence;
- 6) a 3' to 5' RNA coding region;
- and 7) a 5' non-coding RNA sequence, wherein components 1 thru 7 are from the same species of non-segmented respiratory syncytial virus.
A pure, recombinant, replicating and non-spreading non-segmented RNA virus particle, comprising:
- 1) a functional non-segmented respiratory syncytial virus RNA dependent RNA polymerase (L);
- 2) a non-segmented respiratory syncytial virus phosphoprotein (P);
- 3) a non-segmented respiratory syncytial virus nucleocapsid (N);
- 4) necessary respiratory syncytial virus infection proteins;
- 5) a 3' non-coding RNA sequence;
- 6) a 3' to 5' RNA coding region, which encodes said non-segmented virus L, P, N, but no non-segmented virus structural proteins required for assembly of budded infectious particles;
- and 7) a 5' non-coding RNA sequence, wherein components 1 thru 7 are from the same species of non-segmented respiratory syncytial virus.
A pure, recombinant, virus particle, comprising:
- 1) a functional non-segmented respiratory syncytial virus RNA dependent RNA polymerase (L);
- 2) a non-segmented respiratory syncytial virus phosphoprotein (P);
- 3) a non-segmented respiratory syncytial virus nucleocapsid (N);
- 4) non-segmented respiratory syncytial virus structural proteins;
- 5) a 3' non-coding RNA sequence;
- 6) a 3' to 5' RNA coding region;
- and 7) a 5' non-coding RNA sequence, wherein components 1 thru 7 are from the same species of non-segmented respiratory syncytial virus.
A method for recovering wildtype or recombinant negative stranded, non-segmented respiratory syncytial virus genomes, comprising;
- transfecting a cultured host cell with one or more nucleic acid molecules, coding for:
- 1) a functional non-segmented respiratory syncytial virus RNA dependent RNA polymerase (L);
- 2) a non-segmented respiratory syncytial virus phosphoprotein (P);
- 3) a non-segmented respiratory syncytial virus nucleocapsid (N);
- 4) a 3' non-coding RNA sequence;
- 5) a 3' to 5' RNA coding region;
- and 6) a 5' non-coding RNA sequence, wherein components 1 thru 6 are from the same species of non-segmented respiratory syncytial virus, and wherein components 1 thru 6 are expressed in said transfected host cell and are operably linked to form said virus genome.
Dependencies are inferred from the claim text.